The retinoblastoma family of nuclear factors is composed of RB, the prototype of the tumour suppressor genes and of the strictly related genes p107 and Rb2/p130. The three genes code for proteins, namely pRb, p107 and pRb2/p130, that share similar structures and functions. These proteins are expressed, often simultaneously, in many cell types and are involved in the regulation of proliferation and differentiation. We determined the expression and the phosphorylation of the RB family gene products during the DMSO-induced differentiation of the N1E-115 murine neuroblastoma cells. In this system, pRb2/p130 was strongly up-regulated during mid-late differentiation stages, while, on the contrary, pRb and p107 resulted markedly decreased at late stages. Differentiating N1E-115 cells also showed a progressive decrease in B-myb levels, a proliferation-related protein whose constitutive expression inhibits neuronal differentiation. Transfection of each of the RB family genes in these cells was able, at different degrees, to induce neuronal differentiation, to inhibit [ 3 H]thymidine incorporation and to down-regulate the activity of the B-myb promoter.
Introduction
RB,p107 and Rb2/p130 are the three genes of the retinoblastoma family. Among these, RB, responsible for the susceptibility to retinoblastoma, is the prototype of the tumour suppressor genes, whose inactivation is causally related to cancer (Klein, 1987; Weinberg, 1995; Sang et al, 1995) . The products of RB genes are the phosphoproteins pRb, p107 and pRb2/p130, characterised by a peculiar conformational domain, termed`pocket', which is involved in most of their functionally relevant protein-protein interactions (Riley et al, 1994; Paggi et al, 1996) . Pocket proteins are negative controllers of cell proliferation (Huang et al, 1988; Zhu et al, 1993; Claudio et al, 1994) , in part through their ability to interact with members of the E2F family of transcription factors (Sidle et al, 1996) . Since growth arrest is a prerequisite for differentiation in many cell types, this might in part explain the involvement of RB, p107 and Rb2/p130 in differentiative processes and in embryonic development as well (Chen et al, 1989 (Chen et al, , 1995 Coppola et al, 1990; Gu et al, 1993; Lee et al, 1992 Lee et al, , 1994 Martelli et al, 1994; Jacks et al, 1992) . Besides E2F sequestering, the role of RB in differentiation appears to be exerted through transcriptional regulation of differentiationspecific genes (Chen et al, 1996; Rohde et al, 1996) . Furthermore, cell cycle regulatory proteins which modify pRb phosphorylation and its affinity for E2F play an important role in the differentiation of murine neuroblastoma N1E-115 cells (Kranenburg et al, 1995) .
Neuroblastoma (NB), the most common non-cranial solid tumour of childhood, arises from the embryonic neural crest cells arrested at an early stage of differentiation (Helman et al, 1987) . In vivo (Everson, 1964) as well as in vitro (Tsokos et al, 1986) , NB cells can undergo neural differentiation, recapitulating the potential of the neural crest. The molecular basis of NB differentiation is largely unknown, but proto-oncogene expression is widely modulated during this process (Schwab, 1993) . The expression of B-myb is down-regulated during differentiation and its constitutive expression inhibits neuronal differentiation (Raschella Á et al, 1995) . The B-myb promoter region contains an E2F site (Lam and Watson, 1993; Lam et al, 1995) the mutation of which causes constitutive activation of B-myb transcription. In the cell cycle, B-myb promoter is repressed in G 0 and early to middle G 1 , to become active at the G 1 /S boundary (Lam and Watson, 1993) . By in vivo footprinting experiments, it has been demonstrated that in proliferating cells, where B-myb transcription is active, the E2F site in the B-myb promoter is not occupied (Zwicker et al, 1996) . These data indicate that E2F site is important for negative regulation rather than for the activation of B-myb transcription. The E2F transcription factors can be complexed with and sequestered by the products of the RB family genes (Cao et al, 1992; Shirodkar et al, 1992; Cobrinik et al, 1993; Beijersbergen et al, 1994; Ginsberg et al, 1994; Hijmans et al, 1995; Johnson, 1995; Sala et al, 1996a ) that negatively modulate E2F activity. Taken together, these observations suggest that B-myb could be a target for negative regulation by the RB gene family during neural differentiation. In addition, it has been recently shown that MYCN overexpression and the heterozygous deletion of RB act synergistically in inducing NB in a transgenic model (Weiss et al, 1997) , stimulating studies on the involvement of the RB genes in the transformation process leading to NB.
In the attempt to unravel some of the molecular mechanisms underlying neural differentiation, we analyzed the role of the pocket genes in inhibiting NB cell proliferation, in promoting NB cell differentiation and in controlling B-myb promoter activity.
Results
Expression of pRb, p107, pRb2/p130 and B-myb during neuronal differentiation Western blot analysis indicated that pRb, p107, pRb2/p130 and B-myb expression was clearly modulated during DMSOinduced differentiation process of N1E-115 NB cells ( Figure  1 ). In untreated cells (Figure 1 , 0 h), the bands corresponding to pRb and pRb2/p130 had a microheterogeneous pattern due to the presence of species with different degrees of phosphorylation (Chen et al, 1989; Beijersbergen et al, 1995; Baldi et al, 1995) . Microheterogeneity was less evident for p107. After 2 h of DMSO treatment (Figure 1 , 2 h), pRb, p107 and pRb2/p130 displayed a hyperphosphorylated, slowmigrating band which for pRb2/p130 became the only detectable form. From 2 to 8 h, pRb2/p130 was detected as a faint, hyperphosphorylated band, while from 24 to 96 h the amount of this protein increased dramatically, with a progressive accumulation of an underphosphorylated, fastmigrating form. On the other hand, the amount of pRb and p107 remained high up to 48 h, drastically falling at 96 h, when pRb was mostly underphosphorylated. B-myb levels decreased during DMSO-induced differentiation, reaching the nadir at 96 h. This finding was consistent with the changes of B-myb mRNA and protein levels detected in differentiating human NB cells (Raschella Á et al, 1995 (Raschella Á et al, , 1996 . Normalisation was done by measuring b-actin levels with a specific monoclonal antibody.
Induction of neuronal differentiation in N1E-115 cells by genes of the RB family
To test whether overexpression of the pocket proteins would be sufficient to induce NB cell differentiation, N1E-115 cells were transfected with the lacZ marker vector in combination with pcDNA3 or the expression vectors for RB, p107 and Rb2/ p130 ( as a positive control, since it has been shown to cause neuronal differentiation in N1E-115 cells (Kranenburg et al, 1995) . Analysis of p107-and Rb2/p130-transfected cells (dark in Figure 2 , panels C and D, respectively) was indicative of the onset of differentiation-related morphologic changes, such as cell flattening and neurite extension. As expected (Kranenburg et al, 1995) , RB-transfected cells clearly showed a more completely differentiated phenotype (Figure 2, panel  B) . Cells transfected with the empty pcDNA3 vector were unchanged (Figure 2A) . To assess whether a strong growth suppressive stimulus was able per se to induce NB differentiation, cells were also transfected with p53. Transfected cells exhibited morphologic changes, such as cell shrinkage and nuclear fragmentation, reminiscent of an apoptotic phenotype ( Figure 2E ). Figure 2F , shows the percentage of differentiated cells (neurite outgrowth longer than the diameter of the cell body) among those transfected with RB family genes. RB was the most efficient differentiation inducer. Cells transfected with each of the three RB family genes were also analyzed by indirect immunofluorescence for the expression of neurofilaments (NF) 160 kDa and b-tubulin. The changes in expression, summarised in Table 1 , were consistent with the induction of a differentiated phenotype (Tsokos et al, 1986; Portier et al, 1982) . After immunodetection, the same fields were scored for b-gal positivity. Together, these data demonstrate that the overexpression of all RB family genes in N1E-115 cells was sufficient to trigger both morphological and biochemical changes specific for neuronal differentiation.
Thymidine incorporation was measured after transfection of N1E-115 cells with each of the RB family genes, p53 or with the empty vector ( Figure 2G ). Among the RB family genes, RB was the most active in inhibiting DNA synthesis, followed by p107 and Rb2/p130. The effect of p53 was not significantly different from that of RB. In each experiment, transfection efficiency assessed by b-gal determination was approximately 30% (not shown) and was comparable in all cases. Thus, the overall inhibitory effect should be estimated accordingly.
Regulation of B-myb promoter activity by RB family genes
Next, we assessed whether the RB family genes might regulate the promoter activity of the B-myb gene. Cotransfections were carried out in exponentially growing N1E-115 cells using the reporter vector pGLHB-myb wt, in which part of the human B-myb promoter containing a functional E2F site was cloned (Lam et al, 1995) , and the expression vectors for RB, P107 or Rb2/p130. As a control, the effect of p53 overexpression, which decreases the levels of B-myb mRNA (Lin et al, 1994) , perhaps acting as an inhibitor of B-myb transcription, was also analyzed. Luciferase assays were carried out in N1E-115 cells grown in basal conditions. Figure  3A shows that B-myb promoter activity was decreased more than fourfold by RB, more than sixfold by p107 and more than twofold by Rb2/p130. The most potent inhibition (more than 20-fold) was brought about by p53. Thus, transfection of p107, RB and Rb2/p130 inhibited the activity of the human B-myb promoter, with a decreasing efficiency. Similar inhibitory effects were also measured in cells treated with DMSO for 48 h (not shown). Next, we asked if the effects of the pocket proteins on the B-myb promoter were dependent upon the presence of the E2F site. To this end, the reporter vector pGLHB-myb (mut), bearing a mutation within the E2F consensus site (Lam et al, 1995) , was used. Figure 3B , shows that, in the case of the RB gene, the inhibitory effect was strictly dependent on the presence of a wild-type E2F binding site. On the other hand, the suppressive effect induced by p107 and, to a lower extent, by Rb2/p130 was Microscopic observations were carried out scoring and photographing at least 200 cells in two different sets of experiments. After immuno¯uorescence detection, the plates were stained for b-gal activity and the same ®elds were observed and photographed. Changes in the intensity of immuno¯uorescence were referred only to the transfected (b-gal positive) cells. Exponentially growing N1E-115 cells were cotransfected with pGLHB-myb wt (A) or pGLHB-myb (mut) (B) with the RB family genes or p53 expression plasmids indicated in each panel. Luciferase activity is given relative to that of the promoterless luciferase plasmid pGL2-basic (assigned a value of unity). Results are given as the average+ S.D. of four independent experiments less dependent upon the presence of an intact E2F binding site. Luciferase activity from vector pGLHB-myb (mut) resulted strongly repressed by p53.
Since pocket proteins associate with different affinities with the members of the E2F family, we tested whether overexpression of the E2F4 gene product, a preferential partner for p107 and pRb2/p130 (Ginsberg et al, 1994; Beijersbergen et al, 1994; Vairo et al, 1995) , could influence the inhibitory activity of RB proteins. E2F4 lacked a transactivation effect on the B-myb promoter, but, when cotransfected with Rb2/p130, inhibited the B-myb promoter more than Rb2/p130 alone (data not shown).
Discussion
Despite the remarkable structural and functional similarities among the members of the RB family, they do not exert overlapping functions, as suggested by the distinct phenotype associated with targeted disruption of RB, as compared to those of the p107, Rb2/p130 and p107-Rb2/p130 double knock-out mice (Lee et al, 1992; Jacks et al, 1992; Cobrinik et al, 1996) . The aim of our work was to analyze, in the same cellular context, the expression of the three members of the RB family genes and their role in differentiation control and in modulating the promoter activity of B-myb, a gene involved in the regulation of proliferation and differentiation in various cell types (Sala and Calabretta, 1992; Raschella Á et al, 1995) .
In DMSO-induced differentiation of N1E-115 neuroblastoma cells (Figure 1 ), pRb2/p130 strongly accumulated at late stages of differentiation while pRb and p107 levels were markedly decreased. Quantitative determination could, however, underestimate underphosphorylated pRb, since this form is more strongly associated with the nuclear matrix and is more difficult to extract in the presence of non-ionic detergents (Mittnacht and Weinberg, 1991; Mancini et al, 1994) . However, differentiation was associated with accumulation of underphosphorylated pRb, which is active in inducing growth suppression. It is worth to note that, at early stages after induction of differentiation (2 h), all three pocket proteins displayed an hyperphosphorylated, fast-migrating band, which was absent in asynchronous cells (0 h). Being these hyperphosphorylated forms inactive as cell cycle negative regulators, it could be argued that N1E-115 cells could need to undergo one or more complete mitotic cycles before completing the differentiation process. This is the case of confluent 3T3-L1 mouse adipocytes induced to differentiation (Richon et al, 1997) .
Over-expression of all retinoblastoma family members was associated with a decreased [ 3 H]thymidine incorporation and with induction of differentiation in N1E-115 cells, both according to morphological (neurites outgrowing, cell flattening) and to immunohistochemical criteria. In fact, all the three pocket genes were able to elicit a decrease in the expression of b-tubulin and an increase in the levels of NF 160 kDa. NF 160 kDa determination was chosen as a marker for specific neuronal differentiation, because it marks an intermediate level of differentiation, between the expression of NF 68 kDa and that of NF 200 kDa (Bennett and DiLullo, 1985) .
We were concerned about the possibility that the induction of differentiation by the pocket genes could be secondary to the inhibition of proliferation. Thus, we asked whether a strong growth suppressive stimulus was able per se to induce neuroblastoma cell differentiation. Accordingly, N1E-115 cells were transfected also with p53, a gene with well known growth and tumour suppressor properties, but structurally and functionally different from genes of the RB family (Harris, 1996) . p53 growth arrest gave rise to peculiar morphological changes which did not have any of the characteristics of neural differentiation but, rather, were reminiscent of an apoptotic phenotype. No further analysis was performed to verify if p53 overexpression resulted in apoptosis of N1E-115 cells, but induction of apoptosis in tumour cell lines by wild-type p53 is a well-known phenomenon (Elledge and Lee, 1995; Liebermann et al, 1995; Harris, 1996) . The different behaviour of p53 in comparison to that of RB family genes did not seem to be caused by a more potent growth suppressive effect exerted by p53, since growth analysis did not show significant differences in the effects of p53 and RB (see Figure 2) . Thus, in this model system, it appears that p53 induced cell death, while the growth inhibition caused by RB genes was rather associated with neuronal differentiation. RB exogenous expression was the most efficient in inducing differentiation, numerically and for the extent of the morphological changes.
It is likely that pocket genes act on many cellular targets to induce differentiation. We investigated possible effects at the transcriptional level by assessing whether the RB family genes could regulate the promoter activity of the B-myb gene. The functional interrelationship between RB genes and B-myb was analyzed for several reasons. B-myb expression is down-regulated during differentiation of various cell types, including NB (Bies et al, 1996; Raschella Á et al, 1995 Raschella Á et al, , 1996 . We recently demonstrated that B-myb expression is transcriptionally regulated in neuroblastoma differentiation (Raschella Á et al, 1996) . A decrease in B-myb protein expression was also observed in N1E-115 cells induced to differentiate with DMSO ( Figure  1) , which might represent a prerequisite for differentiation. Noteworthy, the decrease of B-myb expression at late differentiation stages did correlate with an increase of the underphosphorylated active forms of the pocket proteins, albeit in the case of pRb and p107 the total amount of protein was reduced. Finally, the B-myb promoter contains a functional E2F-binding site (Lam and Watson, 1993; Lam et al, 1995) . Accordingly, we evaluated the effect of overexpression of the pocket family genes in modulating the activity of the B-myb promoter in N1E-115 cells, where they were able to induce differentiation. As a control, the effect of p53 was also analyzed. Indeed, pocket genes overexpression was capable to decrease the basal luciferase activity of the construct containing the B-myb promoter. In the case of the RB gene, the effect was strictly dependent on the presence of a wild-type E2F binding site, whereas the suppressive effect induced by p107 and, to a lower extent, by Rb2/p130 was less dependent upon the presence of an intact E2F binding site. This suggests that the effect of p107 and Rb2/p130 might be due to interaction with and inactivation of positive regulator(s) of B-myb transcription. Noteworthy, it has been recently reported that the p107 protein binds to B-myb and suppresses its autoregulatory activity in SAOS-2 human osteosarcoma cells (Sala et al, 1996b) . In the light of the detrimental effect of p53 overexpression in N1E-115 cells, the role of this gene in controlling B-myb promoter activity during differentiation seems unlikely.
In a recent report, we describe that LAN-5 human NB cells, induced to differentiate with retinoic acid, undergo changes in pocket protein expression, which overlap those here described for the N1E-115 cells. Moreover, pRb2/p130 amount and its binding to the B-myb promoter as E2F-pRb2/p130 complex increase throughout the differentiation process, where E2F4 is up-regulated and undergoes changes in sub-cellular distribution (Raschella Á et al, 1997) .
Taken together, our findings show, for the first time, that p107 and Rb2/p130 induced differentiation and confirm the reported ability of RB to promote growth inhibition and differentiation in NB cells (Kranenburg et al, 1995) . In addition, we propose that, in our model system, RB and p107 could be more substantial in the onset of the differentiation process, while, on the other hand, Rb2/ p130 could play a major role in maintaining the differentiated state. Moreover, the effect on B-myb promoter activity by the RB family genes are consistent with differences in the mechanisms involved in inducing growth arrest and differentiation in NB cells. In fact, while RB-induced repression of B-myb promoter activity was strictly dependent on the presence of an intact E2F site, this was not the case for p107-and Rb2/p130-dependent effects. Our data emphasise the need to take into account the role of active cofactors, such as E2F family members, and their interplay with the RB family gene products for a proper evaluation of the contribution of each pocket protein in the regulation of complex cellular processes, such as growth and differentiation.
Materials and Methods

Cell line
The murine neuroblastoma cell line N1E-115 (Kimhi et al, 1976; Larcher et al, 1992) was maintained in culture and induced to differentiate with DMSO as described (Kranenburg et al, 1995) .
pRb, p107, pRb2/p130 and B-myb analysis in Western blotting Cells (5610 5 ) were lysed in 50 mM Tris-HCl pH 7.4, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 0.1 mM Na 3 VO 4 , 0.1% Triton X-100, 1 mM PMSF and 10 mg/ml leupeptin. After centrifugation, supernatants were transferred to a fresh tube and electrophoresis sample buffer was added. SDS ± PAGE and protein transfer to a PVDF membrane were done as already described . pRb was detected using the G3-245 monoclonal antibody (PharMingen, San Diego, CA); p107 levels were determined using a rabbit polyclonal antibody (sc-318, Santa Cruz Biotechnology, Inc. Santa Cruz, CA); polyclonal antibodies for pRb2/p130 and B-myb detection were described elsewhere (Pertile et al, 1995; Raschella Á et al, 1996) ; anti-b-actin JLA20 monoclonal antibody was purchased from Oncogene Science Inc, Cambridge, MA.
Bands were detected using the ECL reagents (Amersham, Milan, Italy) for chemiluminescence.
Transfections and luciferase assays
Transient transfections were performed as described (Kranenburg et al, 1995) . Expression vectors and the amounts used were: lacZ marker vector (2 mg) (Clontech, Palo Alto, CA); pCMVRB (10 mg), pCMVp107 (10 mg) and pCMVRb2/p130 (10 mg) (Claudio et al, 1994) ; pCMVp53 (10 mg) (Noble et al, 1992) . Luciferase reporter vectors were: pGL2-basic (Promega, Madison, WI), pGLHB-myb wt and pGLHB-myb (mut) (4 mg) (Lam et al, 1995) . pcDNA3 (Invitrogen, San Diego, CA) was used for controls and for balancing the load of DNA. Assays were carried out 36 h after transfection as described (Lam and Watson, 1993) , using the Luciferase Assay kit (Promega, Madison, WI). Samples were quantified using a Lumac Biocounter 2500 luminometer (Lumac, Landgraaf, The Netherlands).
Immuno¯uorescence
Cells were fixed in methanol/acetone (25 : 75) for 20 min at 7208C and processed as described (Raschella Á et al, 1995) . Monoclonal antibodies anti-neurofilaments 160 kDa and anti-b-tubulin (SigmaAldrich, Milan, Italy) were used at 1 : 50 and 1 : 200 dilution, respectively.
Growth analysis
N1E-115 cells were transfected with the expression vectors for RB, p107, Rb2/p130, p53 and with the empty vector pcDNA3. Thirty-six hours later, cells were pulse-labelled for 150 min with 3.7 kBq/ml of [ 3 H]thymidine (2.59 ± 3.33 TBq/mmol, DuPont de Nemours, NEN Products, Cologno Monzese, Milan, Italy) and counted in a Beckman scintillation counter (Beckman Instruments Inc., Fullerton, CA).
